A patient with stage IV type 4 advanced gastric cancer who had a complete pathological response to short-term treatment with S-1 alone

被引:2
|
作者
Ishido, Kenji [1 ]
Koizumi, Wasaburo [1 ]
Tanabe, Satoshi [1 ]
Higuchi, Katsuhiko [1 ]
Sasaki, Tohru [1 ]
Katada, Chikatoshi [1 ]
Azuma, Mizutomo [1 ]
Salgenji, Katsunori [1 ]
Futawatari, Nobue [2 ]
Saegusa, Makoto [3 ]
机构
[1] Kitasato Univ, E Hosp, Dept Gastroenterol, Kanagawa 2288520, Japan
[2] Kitasato Univ, E Hosp, Dept Surg, Kanagawa 2288520, Japan
[3] Kitasato Univ, E Hosp, Dept Pathol, Kanagawa 2288520, Japan
关键词
chemotherapy; gastric cancer; S-1;
D O I
10.1097/CAD.0b013e32830d58a6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An 81-year-old woman presented with dysphagia. Stage IV (cT3, cN3, cH0, cM1) type 4 advanced gastric cancer was diagnosed. The left adrenal gland and the paragastric, mediastinal, and abdominal para-aortic lymph nodes were enlarged. Ascites was present The patient started to receive S-1 (100 mg/day), given orally for 4 weeks followed by 2 weeks of rest. During the first course of treatment, grade 2 anorexia, grade 2 vomiting, and grade 2 diarrhea developed. Treatment with S-1 was therefore discontinued on day 27 The tumor had shrunk and was severely deformed. There was marked narrowing of the pyloric antrum. Abdominal computed tomography revealed that ascites and enlargement of the left adrenal gland and paragastric lymph nodes had resolved. To ensure adequate oral intake and improve the patient's quality of life, a total gastrectomy with a limited (D1) lymph node dissection was performed. The primary gastric tumor, resected lymph nodes, and a peritoneal-lavage specimen were all negative for tumor. Histologically, the tumor had a complete pathological response to S-1. Two years after surgery, the patient is alive, with no evidence of metastasis or recurrence.
引用
收藏
页码:921 / 925
页数:5
相关论文
共 50 条
  • [21] Randomized phase III study of S-1 alone versus S-1 plus docetaxel (DOC) in the treatment for advanced gastric cancer (AGC): The START trial
    Kim, Y. H.
    Koizumi, W.
    Lee, K. H.
    Kishimoto, T.
    Chung, H. C.
    Hara, T.
    Cho, J. Y.
    Nakajima, T.
    Kim, H.
    Fujii, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [22] S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
    Koizumi, Wasaburo
    Narahara, Hiroyuki
    Hara, Takuo
    Takagane, Akinori
    Akiya, Toshikazu
    Takagi, Masakazu
    Miyashita, Kosei
    Nishizaki, Takashi
    Kobayashi, Osamu
    Takiyama, Wataru
    Toh, Yasushi
    Nagaie, Takashi
    Takagi, Seiichi
    Yamamura, Yoshitaka
    Yanaoka, Kimihiko
    Orita, Hiroyuki
    Takeuchi, Masahiro
    LANCET ONCOLOGY, 2008, 9 (03): : 215 - 221
  • [23] Randomized phase III study of S-1 alone versus S-1+cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) SPIRITS: S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer
    Narahara, H.
    Koizumi, W.
    Hara, T.
    Takagane, A.
    Akiya, T.
    Takagi, M.
    Miyashita, K.
    Nishizaki, T.
    Kobayashi, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy
    Guo, Feilong
    Xiang, Xiaosong
    Huang, Yuhua
    Chen, Aoxue
    Ma, Long
    Zhu, Xi
    Abdulla, Zulpikar
    Jiang, Wendi
    Li, Jiafei
    Li, Guoli
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (09) : 1158 - 1165
  • [25] Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy
    Feilong Guo
    Xiaosong Xiang
    Yuhua Huang
    Aoxue Chen
    Long Ma
    Xi Zhu
    Zulpikar Abdulla
    Wendi Jiang
    Jiafei Li
    Guoli Li
    International Journal of Clinical Oncology, 2023, 28 : 1158 - 1165
  • [26] A complete response to S-1 plus cis-diamminedichloroplatinum in advanced-stage esophageal and gastric adenocarcinoma: a case report
    Matsuno, Yoritaka
    Kochi, Mitsugu
    Fujii, Masashi
    Kanamori, Noriaki
    Kaiga, Teruo
    Mihara, Yoshiaki
    Funada, Tomoya
    Miyazaki, Teruyuki
    Takayama, Tadatoshi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [27] A complete response to S-1 plus cis-diamminedichloroplatinum in advanced-stage esophageal and gastric adenocarcinoma: a case report
    Yoritaka Matsuno
    Mitsugu Kochi
    Masashi Fujii
    Noriaki Kanamori
    Teruo Kaiga
    Yoshiaki Mihara
    Tomoya Funada
    Teruyuki Miyazaki
    Tadatoshi Takayama
    World Journal of Surgical Oncology, 10
  • [28] Neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery followed by adjuvant docetaxel and S-1 for patients with large type 3 or type 4 gastric cancer: Short-term outcomes of the phase II OGSG1902 trial
    Miyagaki, Hiromichi
    Goto, Masahiro
    Endo, Shunji
    Tanaka, Ryo
    Omori, Takeshi
    Kawada, Junji
    Takahashi, Naoki
    Masuzawa, Toru
    Furukawa, Haruna
    Sato, Yuya
    Kato, Takeshi
    Fujitani, Kazumasa
    Kawakami, Hisato
    Sakai, Daisuke
    Kurokawa, Yukinori
    Tsujinaka, Toshimasa
    Shimokawa, Toshio
    Satoh, Taroh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer
    Satoh, Seiji
    Okabe, Hiroshi
    Teramukai, Satoshi
    Hasegawa, Suguru
    Ozaki, Nobuhiro
    Ueda, Shugo
    Tsuji, Ayumi
    Sakabayashi, Satomi
    Fukushima, Masanori
    Sakai, Yoshiharu
    GASTRIC CANCER, 2012, 15 (01) : 61 - 69
  • [30] Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
    Kondo, Masato
    Nishino, Shogo
    Yamashita, Daisuke
    Kaihara, Satoshi
    CASE REPORTS IN ONCOLOGY, 2020, 13 (02): : 716 - 720